We are extremely pleased to welcome Aled Williams to Polyneuron as our new Chief Business Officer. Aled brings more than 25 years’ of leadership experience across both pharmaceutical and biotech sectors. Press Release
In other news
-
General
Polyneuron extends Series A to CHF 36.5 millionPolyneuron announces a CHF 14 million extension of the Series… [read on]
-
General
Polyneuron's PN-1007 Receives U.S. FDA Orphan Drug Designation in Anti-MAG NeuropathyPolyneuron is proud to announce that the U.S. Food and… [read on]
-
General
Polyneuron receives approval to begin clinical study with PN-1007 in anti-MAG neuropathyWe are very proud to have received our… [read on]
-
General
Polyneuron announces appointment of chief medical officerWe are extremely pleased to welcome Dr Debra Barker to… [read on]
-
General
Polyneuron annouces appointment of new ChairmanPolyneuron announces the appointment of Ben Machielse as Chairman of… [read on]
-
Financing
Polyneuron raises CHF 22.5 million in a major Series A financingPolyneuron raises CHF 22.5 million in an oversubscribed… [read on]
-
Financing
Completion of financing and team strengtheningPolyneuron announces the completion of a… [read on]
-
Awards
Polyneuron supported by BaseLaunch AcceleratorAfter a first grant of CHF 10’000 during Phase… [read on]